Study ID: ECOG E1808
Description:
Randomized Phase II Trial of Sunitinib/Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features
Location:
Sioux Falls Region
Principal Investigator:
Miroslaw Mazurczak MD
Disease:
REN (Renal)
Stage:
Phase II
Status:
Active - Open to Accrual
For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.
Back to Clinical Trials list